课题基金 / 基金详情

Could GATE-16 help unlock the gate to treatment response in pancreatic ductal adenocarcinoma?

Could GATE-16 help unlock the gate to treatment response in pancreatic ductal adenocarcinoma?
GATE-16 能否帮助打开胰腺导管腺癌治疗反应的大门？
批准号：
495197
负责人：
Chan Jennifer
金额：
$0.11万
依托单位：
B.C. Cancer Research Centre (Vancouver)
依托单位国家：
加拿大
项目类别：
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-10-01 至 2024-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=495197&lang=en
关键词：
Ics Travel Awards

项目摘要

项目成果

Chan Jennifer的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pancreatic ductal adenocarcinoma (PDAC) is the most commonly diagnosed type of pancreatic cancer, which accounts for more than 90% of all diagnoses. Fast progression, late-stage diagnosis, and drug resistance are among factors that make PDAC an aggressive
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using 2D and 3D models to investigate the role of GABARAPL2 in pancreatic ductal adenocarcinoma treatment response